Inhibition of p42 MAPK using a nonviral vector-delivered siRNA potentiates the anti-tumor effect of metformin in prostate cancer cells

Author： Monteagudo Silvia   Pérez-Martínez Francisco C   Pérez-Carrión María D   Guerra Javier   Merino Sonia   Sánchez-Verdú María Prado   Ceña Valentín  

Publisher： Future Medicine

ISSN： 1743-5889

Source： Nanomedicine, Vol.7, Iss.4, 2012-04, pp. : 493-506

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

P-glycoprotein silencing with siRNA delivered by DOPE-modified PEI overcomes doxorubicin resistance in breast cancer cells

By Navarro Gemma   Sawant Rupa R   Biswas Swati   Essex Sean   Tros de Ilarduya Conchita   Torchilin Vladimir P  

Nanomedicine, Vol. 7, Iss. 1, 2012-01 ,pp. : 65-78

Future Medicine

Access to resources Recommend Favorite

Dual effect of metformin on growth inhibition and oestradiol production in breast cancer cells

By            

International Journal of Molecular Medicine, Vol. 35, Iss. 4, 2015-01 ,pp. : 1088-1094

Spandidos Publications

Access to resources Recommend Favorite

Vitamin D3 potentiates the growth inhibitory effects of metformin in DU145 human prostate cancer cells mediated by AMPK/mTOR signalling pathway

By  

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (ELECTRONIC), Vol. 42, Iss. 6, 2015-06 ,pp. : 711-717

John Wiley & Sons Inc

Access to resources Recommend Favorite

Silencing of Polo-Like Kinase (Plk) 1 via siRNA Causes Inhibition of Growth and Induction of Apoptosis in Human Esophageal Cancer Cells

By  

Oncology, Vol. 74, Iss. 3-4, 2008-08 ,pp. : 198-206

Karger

Access to resources Recommend Favorite

Tumor-targeting nanosystems for the delivery of siRNA

By Aigner Achim  

Nanomedicine, Vol. 2, Iss. 4, 2007-08 ,pp. : 569-572

Future Medicine

Access to resources Recommend Favorite